Literature DB >> 26562260

Conditional Deletion of Prolyl Hydroxylase Domain-Containing Protein 2 (Phd2) Gene Reveals Its Essential Role in Chondrocyte Function and Endochondral Bone Formation.

Shaohong Cheng1, Weirong Xing1, Sheila Pourteymoor1, Jan Schulte1, Subburaman Mohan1.   

Abstract

The hypoxic growth plate cartilage requires hypoxia-inducible factor (HIF)-mediated pathways to maintain chondrocyte survival and differentiation. HIF proteins are tightly regulated by prolyl hydroxylase domain-containing protein 2 (Phd2)-mediated proteosomal degradation. We conditionally disrupted the Phd2 gene in chondrocytes by crossing Phd2 floxed mice with type 2 collagen-α1-Cre transgenic mice and found massive increases (>50%) in the trabecular bone mass of long bones and lumbar vertebra of the Phd2 conditional knockout (cKO) mice caused by significant increases in trabecular number and thickness and reductions in trabecular separation. Cortical thickness and tissue mineral density at the femoral middiaphysis of the cKO mice were also significantly increased. Dynamic histomorphometric analyses revealed increased longitudinal length and osteoid surface per bone surface in the primary spongiosa of the cKO mice, suggesting elevated conversion rate from hypertrophic chondrocytes to mineralized bone matrix as well as increased bone formation in the primary spongiosa. In the secondary spongiosa, bone formation measured by mineralizing surface per bone surface and mineral apposition rate were not changed, but resorption was slightly reduced. Increases in the mRNA levels of SRY (sex determining region Y)-box 9, osterix (Osx), type 2 collagen, aggrecan, alkaline phosphatase, bone sialoprotein, vascular endothelial growth factor, erythropoietin, and glycolytic enzymes in the growth plate of cKO mice were detected by quantitative RT-PCR. Immunohistochemistry revealed an increased HIF-1α protein level in the hypertrophic chondrocytes of cKO mice. Infection of chondrocytes isolated from Phd2 floxed mice with adenoviral Cre resulted in similar gene expression patterns as observed in the cKO growth plate chondrocytes. Our findings indicate that Phd2 suppresses endochondral bone formation, in part, via HIF-dependent mechanisms in mice.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26562260      PMCID: PMC4701886          DOI: 10.1210/en.2015-1473

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  61 in total

1.  Inactivation of Vhl in osteochondral progenitor cells causes high bone mass phenotype and protects against age-related bone loss in adult mice.

Authors:  Tujun Weng; Yangli Xie; Junlan Huang; Fengtao Luo; Lingxian Yi; Qifen He; Di Chen; Lin Chen
Journal:  J Bone Miner Res       Date:  2014-04       Impact factor: 6.741

2.  Effect of vitamin K2 and growth hormone on the long bones in hypophysectomized young rats: a bone histomorphometry study.

Authors:  Jun Iwamoto; Tsuyoshi Takeda; Yoshihiro Sato; James K Yeh
Journal:  J Bone Miner Metab       Date:  2007-01-01       Impact factor: 2.626

3.  Conditional disruption of the prolyl hydroxylase domain-containing protein 2 (Phd2) gene defines its key role in skeletal development.

Authors:  Shaohong Cheng; Weirong Xing; Sheila Pourteymoor; Subburaman Mohan
Journal:  J Bone Miner Res       Date:  2014-10       Impact factor: 6.741

4.  Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.

Authors:  Jan H Marxsen; Petra Stengel; Kathrin Doege; Pekka Heikkinen; Terhi Jokilehto; Thomas Wagner; Wolfgang Jelkmann; Panu Jaakkola; Eric Metzen
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

Review 5.  Development of the endochondral skeleton.

Authors:  Fanxin Long; David M Ornitz
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-01-01       Impact factor: 10.005

6.  Up-regulation of glycolytic metabolism is required for HIF1α-driven bone formation.

Authors:  Jenna N Regan; Joohyun Lim; Yu Shi; Kyu Sang Joeng; Jeffrey M Arbeit; Ralph V Shohet; Fanxin Long
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-27       Impact factor: 11.205

7.  Haploinsufficiency of osterix in chondrocytes impairs skeletal growth in mice.

Authors:  Shaohong Cheng; Weirong Xing; Xin Zhou; Subburaman Mohan
Journal:  Physiol Genomics       Date:  2013-08-13       Impact factor: 3.107

Review 8.  HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression.

Authors:  Brian Keith; Randall S Johnson; M Celeste Simon
Journal:  Nat Rev Cancer       Date:  2011-12-15       Impact factor: 60.716

9.  Targeted disruption of ephrin B1 in cells of myeloid lineage increases osteoclast differentiation and bone resorption in mice.

Authors:  Shaohong Cheng; Shien Lucy Zhao; Brittany Nelson; Chandrasekhar Kesavan; Xuezhong Qin; Jon Wergedal; Subburaman Mohan; Weirong Xing
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

10.  Hif-1alpha regulates differentiation of limb bud mesenchyme and joint development.

Authors:  Sylvain Provot; Dawn Zinyk; Yasemin Gunes; Richa Kathri; Quynh Le; Henry M Kronenberg; Randall S Johnson; Michael T Longaker; Amato J Giaccia; Ernestina Schipani
Journal:  J Cell Biol       Date:  2007-04-30       Impact factor: 10.539

View more
  12 in total

Review 1.  The Roles and Mechanisms of Actions of Vitamin C in Bone: New Developments.

Authors:  Patrick Aghajanian; Susan Hall; Montri D Wongworawat; Subburaman Mohan
Journal:  J Bone Miner Res       Date:  2015-10-07       Impact factor: 6.741

2.  Prolyl Hydroxylase Domain-Containing Protein 2 (Phd2) Regulates Chondrocyte Differentiation and Secondary Ossification in Mice.

Authors:  Shaohong Cheng; Patrick Aghajanian; Sheila Pourteymoor; Catrina Alarcon; Subburaman Mohan
Journal:  Sci Rep       Date:  2016-10-24       Impact factor: 4.379

3.  Hypoxia-inducible factor 1-alpha does not regulate osteoclastogenesis but enhances bone resorption activity via prolyl-4-hydroxylase 2.

Authors:  Philippa A Hulley; Tammie Bishop; Aude Vernet; Jurgen E Schneider; James R Edwards; Nick A Athanasou; Helen J Knowles
Journal:  J Pathol       Date:  2017-05-29       Impact factor: 7.996

4.  Conditional Deletion of the Phd2 Gene in Articular Chondrocytes Accelerates Differentiation and Reduces Articular Cartilage Thickness.

Authors:  Shaohong Cheng; Sheila Pourteymoor; Catrina Alarcon; Subburaman Mohan
Journal:  Sci Rep       Date:  2017-03-28       Impact factor: 4.379

5.  Prolyl Hydroxylase Domain-Containing Protein 3 Gene Expression in Chondrocytes Is Not Essential for Bone Development in Mice.

Authors:  Weirong Xing; Sheila Pourteymoor; Gustavo A Gomez; Yian Chen; Subburaman Mohan
Journal:  Cells       Date:  2021-08-26       Impact factor: 7.666

6.  Leucine-rich repeat kinase-1 regulates osteoclast function by modulating RAC1/Cdc42 Small GTPase phosphorylation and activation.

Authors:  Canjun Zeng; Helen Goodluck; Xuezhong Qin; Bo Liu; Subburaman Mohan; Weirong Xing
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-09-06       Impact factor: 4.310

7.  Cortical and trabecular bone are equally affected in rats with renal failure and secondary hyperparathyroidism.

Authors:  Nikita M Bajwa; Cheryl P Sanchez; Richard C Lindsey; Heather Watt; Subburaman Mohan
Journal:  BMC Nephrol       Date:  2018-02-02       Impact factor: 2.388

8.  Experimental repetitive mild traumatic brain injury induces deficits in trabecular bone microarchitecture and strength in mice.

Authors:  Chandrasekhar Kesavan; Nikita M Bajwa; Heather Watt; Subburaman Mohan
Journal:  Bone Res       Date:  2017-12-19       Impact factor: 13.567

Review 9.  Long-term Consequences of Traumatic Brain Injury in Bone Metabolism.

Authors:  Nikita M Bajwa; Chandrasekhar Kesavan; Subburaman Mohan
Journal:  Front Neurol       Date:  2018-03-05       Impact factor: 4.003

Review 10.  Hypoxia-Inducible Factor and Its Role in the Management of Anemia in Chronic Kidney Disease.

Authors:  Joshua M Kaplan; Neeraj Sharma; Sean Dikdan
Journal:  Int J Mol Sci       Date:  2018-01-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.